(DENVER)Israeli generic drug maker Teva Pharmaceutical Industries Ltd. on Tuesday completed a $360 million acquisition of Bentley Pharmaceuticals Inc., which will expand its operations in ...READ MORE
(EXETER, N.H.)Bentley Pharmaceuticals Inc. said Thursday shareholders will receive a slightly lower price from purchaser Teva Pharmaceutical Industries Ltd. now that Bentley has spun off its dru...READ MORE
(EXETER, N.H.)Generic drug maker Bentley Pharmaceuticals Inc. said Thursday its board approved the spin-off of its drug delivery business into a new company named CPEX Pharmaceuticals Inc.READ MORE
(NEW YORK)Israeli generic drug maker Teva Pharmaceutical Industries Ltd. said Monday it will pay $360 million in cash for Bentley Pharmaceuticals Inc. in a move to expand operations in Spain...READ MORE
(EXETER, N.H.)Bentley Pharmaceuticals Inc., which markets generic and branded drug products, said Wednesday its European subsidiaries received approvals to market a generic version of AstraZenec...READ MORE
(EXETER, N.H.)Bentley Pharmaceuticals Inc. said Thursday it plans to split its drug delivery division into a separate company so it can focus on developing generic drugs.READ MORE